-
Citigroup Slashes Price Target On This Stock By 83%; Also Check Out Some Other Big PT Changes
Wednesday, August 10, 2022 - 7:42am | 422RBC Capital cut the price target for Nuvei Corporation (NASDAQ: NVEI) from $80 to $60. Nuvei shares fell 21.5% to close at $33.03 on Tuesday. Piper Sandler increased the price target on Masimo Corporation (NASDAQ: MASI) from $130 to $135. Masimo shares fell 4.2% to close at $148.17 on Tuesday....
-
Masimo Clocks 85% Jump In Quarterly Sales, Provides Q3 Guidance Below Expectations
Wednesday, August 10, 2022 - 5:59am | 260Masimo Corp's (NASDAQ: MASI) Q2 revenue increased 85.3% Y/Y to $565.3 million, beating the consensus of $540.56 million. Healthcare revenue was $357.0 million, +17% on reported basis and 19.0% on constant currency. Non-healthcare revenue was $208.3 million. Excluding...
-
Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session
Monday, August 8, 2022 - 12:49pm | 2645Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6 million for fiscal year ended March 31, 2022. Magic Empire Global Limited (NASDAQ: MEGL) surged 110...
-
Neurocrine Biosciences Shares Jump After Raising Ingrezza Sales Guidance
Friday, August 5, 2022 - 11:33am | 350Tucked in its Q2 earning release, Neurocrine Biosciences Inc (NASDAQ: NBIX) said that in August, the Phase 2a study of NBI-827104 in essential tremor did not meet specified endpoints. Based on the totality of data from the Phase 2a study, at this time, the company will not proceed...
-
eBay To $59? Plus Goldman Sachs Predicts This PT For Costco Wholesale
Thursday, August 4, 2022 - 9:15am | 423Piper Sandler cut the price target for eBay Inc. (NASDAQ: EBAY) from $63 to $59. eBay shares rose 0.5% to $50.75 in pre-market trading. Goldman Sachs reduced the price target on Match Group, Inc. (NASDAQ: MTCH) from $105 to $80. Match Group shares rose 0.6% to $63.60 in pre-market trading....
-
McKesson Boosts FY23 Outlook Backed By Strong Contribution From COVID-19 Drugs
Thursday, August 4, 2022 - 7:40am | 275McKesson Corp (NYSE: MCK) reported Q1 FY23 adjusted EPS of $5.83, +5% Y/Y, beating the consensus of $5.27. Revenues increased 7% Y/Y to $67.15 billion, surpassing the consensus of $65.14 billion. U.S. Pharmaceutical segment's revenues were $56.9 billion, +14%, driven by an increased...
-
More Than $40 Million Bet On This Penny Stock? Check Out These 3 Penny Stocks Insiders Are Buying
Tuesday, August 2, 2022 - 9:16am | 489U.S. gold futures traded higher this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider...
-
Airbnb To $145? Here Are 5 Other Price Target Changes For Monday
Monday, August 1, 2022 - 7:48am | 313Keybanc cut the price target on Airbnb, Inc. (NASDAQ: ABNB) from $195 to $145. However, Keybanc analyst Justin Patterson maintained the stock with an Overweight. Airbnb shares rose 0.7% to $111.70 in pre-market trading. Wells Fargo boosted Colgate-Palmolive Company (NYSE: CL) price target from...
-
Why Amazon Is Trading Higher By 12%: Here Are 23 Stocks Moving Premarket
Friday, July 29, 2022 - 6:50am | 951Gainers Getty Images Holdings, Inc. (NYSE: GETY) rose 104.5% to $21.47 in pre-market trading. ThermoGenesis Holdings, Inc. (NASDAQ: THMO) rose 34.3% to $0.2850 in pre-market trading after gaining over 6% on Thursday. ECB Bancorp, Inc. (NASDAQ: ECBK) rose 34.1% to $18.90 in pre-market trading after...
-
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
Friday, July 29, 2022 - 5:55am | 3249Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11, 2022. SKYX Platforms Corp. (NASDAQ: SKYX) gained 68.6% to settle at $7.03. Benchmark initiated...
-
Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session
Thursday, July 28, 2022 - 12:41pm | 2299Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) gained 231% to $2.63 on news that the company will be acquired By Henry Crown and Company for $3.25 per share. Petros Pharmaceuticals, however, confirmed that a press release regarding a purported acquisition of the company was fraudulent and not...
-
Benzinga Before The Bell: Apple's Latest Move For Self-Driving Car Project, Monkeypox Is A National Emergency, Spirit-Jet Blue Merger And Other Top Financial Stories Thursday, July 28
Thursday, July 28, 2022 - 8:32am | 3109Reuters Monkeypox A Nationally Notifiable Condition, CDC Poised To Announce: Report Reuters reported that the U.S. Centers for Disease Control and Prevention (CDC) plans to make monkeypox infection a nationally notifiable condition. The CDC said that the designation would be effective from next...
-
Labcorp To Spin Off Its Clinical Trial Business, Posts Mixed Q2 Earnings
Thursday, July 28, 2022 - 7:44am | 348Laboratory Corp of America Holdings (NYSE: LH) plans to spin off its unit focused on the clinical development business. Wall Street Journal was the first to report the news. The clinical drug trial business operates as a Contract Research Organization, providing Phase I-IV...
-
Why Meta Platforms Is Trading Lower By More Than 6%: Here Are 34 Stocks Moving Premarket
Thursday, July 28, 2022 - 6:09am | 1382Gainers JAKKS Pacific, Inc. (NASDAQ: JAKK) rose 34.7% to $23.01 in pre-market trading after the company reported better-than-expected Q2 results. Athersys, Inc. (NASDAQ: ATHX) rose 35.1% to $0.2568 in pre-market trading after gaining 10% on Wednesday. Athersys is expected to release its Q2...
-
Recap of Wednesday's Biotech Catalysts - End of The Day Summary
Wednesday, July 27, 2022 - 7:00pm | 1148IDEAYA Biosciences (NASDAQ: IDYA) has entered into a clinical trial collaboration and supply agreement with Amgen Inc. to evaluate the efficacy and safety of IDE397 with Amgen's AMG 193 in a Phase 1 clinical trial. IDEAYA shares traded in a range of $14.59 to $15.82 on a day volume of...